Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 68001-706

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg_10ml Carton Label (Doxorubicin HCl Liposome Injection Carton Label 20mg 10ml)

Packaging label for doxorubicin hydrochloride liposome injection, 2 mg/mL (20 mg/10 mL) by BluePoint Laboratories. The label states it is a liposomal formulation and emphasizes it should not substitute for doxorubicin hydrochloride. The product is for intravenous infusion only after dilution, comes in a 10 mL single-dose vial, and includes handling instructions such as refrigeration and discarding unused portions. Manufactured by Alembic Pharmaceuticals Limited, with a product of Germany note.*

FDA Label Image

50mg_25ml Carton Label (Doxorubicin HCl Liposome Injection Carton Label 50mg 25ml)

Packaging label for doxorubicin hydrochloride liposome injection, 50 mg/25 mL (2 mg/mL) by BluePoint Laboratories. The label states this is a liposomal formulation for intravenous use, single-dose vial, with storage instructions at 2° to 8°C and warnings not to freeze. It includes active ingredients and excipient details, manufacturer information (Alembic Pharmaceuticals, India), and emphasizes the product is cytotoxic and not to be substituted.*

FDA Label Image

20mg_10ml Vial Label (Doxorubicin HCl Liposome Injection Vial Label 20mg 10ml)

Label for Doxorubicin Hydrochloride liposomal injection, 20 mg/10 mL (2 mg/mL) single-dose vial by BluePoint Laboratories. The label includes usage instructions, storage conditions, a barcode, lot number, and expiration date. It highlights that the product is a liposomal formulation and cautions against substitution for standard doxorubicin hydrochloride.*

FDA Label Image

50mg_25ml Vial Label (Doxorubicin HCl Liposome Injection Vial Label 50mg 25ml)

Label for Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) in a 25 mL single-dose vial. The product is a liposomal formulation indicated for intravenous infusion, with warnings not to substitute this formulation for non-liposomal doxorubicin. Manufactured by a pharmaceutical company in India for BluePoint Laboratories, and marked as Rx only.*

FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

A Kaplan-Meier survival curve chart comparing progression-free survival between two groups: Doxorubicin HCl + Bortezomib and Bortezomib alone. The y-axis shows the percent of subjects who are progression-free, and the x-axis shows time in months. The chart includes p-value and hazard ratio (HR) with confidence intervals, along with the number of subjects at risk over time for each group.*

FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

Chemical structure diagram of the active ingredient doxorubicin hydrochloride, showing its molecular groups and bonds, annotated with variables m and n representing values of 14 or 16.*

FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

Chemical structure diagram of doxorubicin hydrochloride, showing the molecular components and arrangement including chains, bonds, and sodium ion.*

FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

An illustration diagram depicting the structural composition of liposomal doxorubicin hydrochloride. It labels the outer MPEG-DSPE coating, the liposomal bilayer beneath it, and the aqueous core containing entrapped doxorubicin HCl at the center.*

FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

Chemical structure of doxorubicin hydrochloride showing its molecular arrangement including rings, hydroxyl groups, and associated atoms clearly depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.